Developments in neurogenetics have been amazing. New genes have been described for neurological disorders and psychiatric diseases.We live in a time when technology matters more than ever. However, these new advances in neurogenetics are bringing complex ethical dilemmas. We should exert extreme caution against reductionism in psychiatry and neurology. As J. Kagan elegantly said: “Biology does not determine the personality, it contributes to it.”
C. Rieubland et al. discuss the need for multidisciplinarity in neurogenetics’ clinic in order to offer comprehensive care in genetic diagnosis,counselling and screening.
Genetic testing in psychiatric diseases, for example in bipolar disorders as discussed by A. Malafosse, is a difficult endeavour, since in this clinical field the debate of nature versus nurture remains of paramount importance.
V. Cina and F. Fellmann discuss the implications of predictive testing in neurodegenerative disorders. Awareness of risk status has a profound impact not only on individuals but also on their families. The ethical principles of autonomy and confidentiality deserve our utmost attention.
M. Preisig reviews the state of the art of genetics of bipolar disorders. The overlap in the biological basis that predisposes to both schizophrenia and bipolar disorder may have implications for the classification of these major psychiatric diseases.
Huntington’s disease – a well-known disorder to both psychiatrists and neurologists – has been one of the most thoroughly investigated neurodegenerative diseases from a genetic point of view. C.Wider and R. Lüthi-Carter discuss some of the prevalent theories on pathogenesis and possible new approaches to treatment.
The mutations in the FMR1-gene family are responsible for the most common cause of inherited mental retardation as well as another condition characterised by progressive cerebellar ataxia. S. Jaquemont provides an update on recent advances in the fragile X-field. The enormous development in neurogenetics poses a huge challenge to professionals and will require continuous efforts in education of doctors and information of patients.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.